Breaking News
Get 40% Off 0
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks
Close

Relief Therapeutics Holding SA (RLFB)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
1.3000 +0.0500    +4.00%
26/04 - Closed. Currency in CHF ( Disclaimer )
Type:  Equity
Market:  Switzerland
ISIN:  CH1251125998 
VALOR:  125112599
  • Volume: 1,335
  • Bid/Ask: 1.3000 / 1.3200
  • Day's Range: 1.2550 - 1.3000
Relief Therapeutics 1.3000 +0.0500 +4.00%

RLFB Recent Sentiments

 
This page contains information on users’ sentiments for the Relief Therapeutics Holding SA stock, which are displayed both on charts of different periods of time and on a detailed table.
BearishBullish
Start Date Username Call Open Rate End Date Chg. %
Apr 11, 2024 Bayram Bitmez   1.3000 0.00%
Mar 13, 2024 laurent truffer   1.4400 Apr 05, 2024 @ 1.3500 -6.25%
Feb 26, 2024 Alexandre Pereira   1.6100 Mar 04, 2024 @ 1.4500 -9.94%
Feb 14, 2024 Nadir Sutter   1.6360 Mar 08, 2024 @ 1.4500 -11.37%
Jan 30, 2024 Claus Schmid   1.6600 Feb 23, 2024 @ 1.6000 +3.61%
Jan 12, 2024 Grzegorz Lis   1.7320 Feb 02, 2024 @ 1.6920 -2.31%
Sep 05, 2023 Joerg Steinborn   4.4400 Nov 30, 2023 @ 1.8600 -58.11%
Sep 04, 2023 Marco Singarella   3.8900 Nov 30, 2023 @ 1.8600 -52.19%
Sep 04, 2023 Mišo Matić   3.9800 Nov 30, 2023 @ 1.8600 -53.27%
Sep 01, 2023 Andre Hauger   3.7700 Nov 30, 2023 @ 1.8600 -50.66%
Sep 01, 2023 IOANNIS RETSOS   3.3300 Nov 30, 2023 @ 1.8600 -44.14%
Aug 14, 2023 Auguste Castella   2.3650 Oct 13, 2023 @ 2.2000 -6.98%
Aug 02, 2023 Giu Vel   2.5850 Nov 30, 2023 @ 1.8600 -28.05%
Jul 28, 2023 Sasa Aleksandar   2.5950 Nov 30, 2023 @ 1.8600 +28.32%
Jul 27, 2023 Pierre Renevey   2.5000 Nov 30, 2023 @ 1.8600 +25.60%
Jul 20, 2023 Mostafa Yusif   2.6500 Nov 30, 2023 @ 1.8600 +29.81%
Jul 14, 2023 Mišo Matić   2.6300 Aug 03, 2023 @ 2.5100 -4.56%
Jun 27, 2023 Olivier Probst   2.6150 Nov 30, 2023 @ 1.8600 -28.87%
Jun 23, 2023 Felix Beck   3.0500 Nov 30, 2023 @ 1.8600 -39.02%
Jun 16, 2023 hüseyin argun   3.5800 Nov 30, 2023 @ 1.8600 -48.04%
Jun 15, 2023 Jan Gysbrechts   3.4000 Nov 30, 2023 @ 1.8600 -45.29%
Jun 08, 2023 Mostafa Yusif   2.9800 Jul 13, 2023 @ 2.6250 +11.91%
Jun 05, 2023 Lorenzo Huesler   3.5600 Nov 30, 2023 @ 1.8600 +47.75%
May 23, 2023 Mostafa Yusif   4.9900 Jun 07, 2023 @ 3.4050 +31.76%
May 23, 2023 Aniceto Rodríguez   4.9550 Nov 30, 2023 @ 1.8600 -62.46%
May 22, 2023 Mostafa Yusif   5.0000 May 23, 2023 @ 4.9900 +0.20%
May 22, 2023 Claus Schmid   5.2000 Nov 30, 2023 @ 1.8600 -64.23%
May 22, 2023 Mostafa Yusif   5.3300 May 22, 2023 @ 5.0000 +6.19%
May 19, 2023 Michael Albiez   6.1000 Nov 30, 2023 @ 1.8600 +69.51%
May 16, 2023 מאור דוויק   6.5000 Nov 30, 2023 @ 1.8600 -71.38%
May 12, 2023 Ali Rif   6.7900 Nov 30, 2023 @ 1.8600 -72.61%
May 09, 2023 Mostafa Yusif   7.4300 May 22, 2023 @ 5.3300 +28.26%
May 09, 2023 Mario Ravasio   7.4300 Nov 30, 2023 @ 1.8600 -74.97%
May 08, 2023 Jorge Juan   6.2000 Nov 30, 2023 @ 1.8600 +70.00%
May 05, 2023 ala zam   7.0500 Nov 30, 2023 @ 1.8600 -73.62%
May 05, 2023 Warren Marsh   7.8900 Nov 30, 2023 @ 1.8600 -76.43%
May 05, 2023 Antonio Caetano   7.8900 Nov 30, 2023 @ 1.8600 -76.43%
May 05, 2023 Lior Vilenski   8.0500 Nov 30, 2023 @ 1.8600 -76.89%
May 03, 2023 Jan Gysbrechts   7.2000 Jun 15, 2023 @ 3.4000 -52.78%
May 02, 2023 Gildo Gienola   7.0000 Nov 30, 2023 @ 1.8600 -73.43%
Apr 28, 2023 Markus Woelfler   7.2400 Nov 30, 2023 @ 1.8600 -74.31%
Apr 27, 2023 Lorenzo Husler   6.8400 Nov 30, 2023 @ 1.8600 -72.81%
Apr 25, 2023 laurent truffer   7.2000 Nov 30, 2023 @ 1.8600 -74.17%
Apr 20, 2023 Franco Polloni   7.2000 Nov 30, 2023 @ 1.8600 +74.17%
Apr 17, 2023 Ettore Colombini   0.0189 Apr 24, 2023 @ 0.0177 -6.35%
Apr 14, 2023 Mario Ravasio   7.4800 May 09, 2023 @ 7.4300 -0.67%
Apr 14, 2023 Natalia Gofman   0.0191 Apr 17, 2023 @ 0.0185 -3.14%
Apr 11, 2023 marco pisano   8.0000 May 09, 2023 @ 7.4300 +7.13%
Apr 03, 2023 Bekir Kıratoğlu   8.1200 May 09, 2023 @ 7.4300 -8.50%
Apr 03, 2023 Mostafa Yusif   7.8000 May 09, 2023 @ 7.4300 +4.74%
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

RLFB Comments

Write your thoughts about Relief Therapeutics Holding SA
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
Carlos Medina
Carlos Medina Jan 05, 2022 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Reason for the spike? Still pump and dump?
Laurent Loboss Badoud
Laurent Loboss Badoud Jan 05, 2022 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Relief Therapeutics: Nrx wants to patent its anti-COVID formulation of aviptadil
Marco Singarella
Marco Singarella Jan 05, 2022 10:54AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Still pump and dump. Is it now a good time to buy?
Mohamed Nedif
Mohamed Nedif Nov 12, 2021 3:35AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
https://www.relieftherapeutics.com/newsblog/relief-reports-that-its-u-s-collaboration-partner-has-announced-it-has-received-a-u-s-food-and-drug-administration-review-of-aviptadil-manufacturing-information
Carlos Medina
Carlos Medina Oct 20, 2021 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
With the lawsuit it's pretty much the end for this thing, right?
Marco Singarella
Marco Singarella Oct 20, 2021 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Which lawsuit?
Marco Singarella
Marco Singarella Oct 20, 2021 11:21AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Just found this now. Yes sounds the end
Marco Singarella
Marco Singarella Sep 22, 2021 3:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
good time to buy now. will definitely go up in the next few weeks
Carlos Medina
Carlos Medina Sep 22, 2021 3:32AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Based on?
Jaroslav Kovacik
Jaroslav Kovacik Sep 07, 2021 10:03AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
2q 2022 gona bi big
Douglas Boggs
Douglas Boggs Jul 29, 2021 7:47AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Lots of potential but Still no revenue to report
Carlos Medina
Carlos Medina Jul 29, 2021 6:06AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock is puzzling. No updates, suddenly up 20.30% out of the blue. This week, it's secured more funding, completed acquisitions, Aviptadil gets approval in Georgia plus commercial formulation... and the stock is down about 6-7% .... SMH x-/
Carlos Medina
Carlos Medina Jul 27, 2021 3:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Ok this is bigNRx Pharmaceuticals Announces Emergency Use Authorization of ZYESAMI™ (aviptadil) in Nation of Georgia
Jason Conway
Jason Conway Jul 27, 2021 3:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Turns out it wasn’t that big…
Krava Tsakosh
Krava Tsakosh Jun 08, 2021 10:48AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
That's a nice start of the week
Carlos Medina
Carlos Medina May 21, 2021 12:08PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
This stock keeps doing this, falls gradually and then it's pumped o and volume another 20% only to fall again due to lack of news and meaningful updates.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email